Favorable coronary outcomes following IL-6 blockade with tocilizumab in IVIG-resistant kawasaki disease: a case series
ObjectiveTo evaluate the efficacy and coronary outcomes of tocilizumab (TCZ) in patients with intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD), and to place these findings against the conflicting available evidence.MethodsWe retrospect…